Reexamination of Patents Listed in the FDA's Orange Book: Surprising Facts For Brands and Generics
02.02.10 IPWatchdog
In this article, SKGF Director, Gaby Longsworth shares some interesting statistics on patent reexam specifically related to brand and generic pharmaceuticals. Click here to read the full article.

twitter